drugset / Trial / NCT04016051

Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections

NCT04016051

Phase 3 Completed 265 enrolled Grünenthal GmbH
RandomizedParallel-groupOpen-labelTreatment

Summary

This study was performed in children with upper respiratory tract infections (acute ear infection, infection of the tonsils or throat, or bacterial inflammation of the bronchi) who needed treatment with an antibiotic (clarithromycin). The study investigated a new technology which delivers the antibiotic in a straw (dose sipping technology, DST) in comparison to a marketed syrup.

Timeline

Start
2004-09-22
Primary completion
2004-12-23
Completion
2004-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Clarithromycin Small molecule 125 mg Oral
Subject Clarithromycin Small molecule 187.5 mg Oral
Subject Clarithromycin Small molecule 250 mg Oral